Preliminary study of contrast-enhanced harmonic endosonography with second-generation contrast agents

Journal of Medical Ultrasonics

Volumn 35, Issue 1, 2008, Pages 11-18

  Kitano, Masayuki ^a   Kudo, Masatoshi ^a   Sakamoto, Hiroki ^a   Nakatani, Tatsuya ^a   Maekawa, Kiyoshi ^a   Mizuguchi, Nobuyuki ^a   Ito, Yasuhiro ^b   Miki, Motohiro ^b   Matsui, Uwe ^c   Von Schrenck, Tammo ^c  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Aloka Co Ltd   (Japan)

^c Allgemeines Krankenhaus Eilbek   (Germany)

Author keywords

Contrast enhanced harmonic endosonography; Microcirculation

Indexed keywords

CONTRAST MEDIUM; SONOVUE;

ARTICLE; CASE REPORT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; ENDOSCOPIC ECHOGRAPHY; GALLBLADDER; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PANCREAS CARCINOMA; PHANTOM; STOMACH WALL; ULTRASOUND;

EID: 41049108501     PISSN: 13464523     EISSN: 16132254     Source Type: Journal    
DOI: 10.1007/s10396-007-0167-6     Document Type: Article

References (31)

1. Ding H, Kudo M, Onda H, et al. Evaluation of post-treatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001;221:721-730.
2. Oshikawa O, Tanaka S, Ioka T, et al. Dynamic sonography of pancreatic tumors: comparison with dynamic CT. AJR 2002;178:1133-1137.
3. Kudo M. Contrast harmonic imaging in the diagnosis and treatment of hepatic tumors. Tokyo: Springer; 2003.
4. Minami Y, Kudo M, Kawasaki T, et al. Evaluation of the effectiveness of transcatheter arterial chemoembolization for hepatocellular carcinoma: value of coded phase-inversion harmonics. AJR 2003;180:703-708.
5. Nagase M, Furuse J, Ishii H, Yoshino M. Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 2003;22:789-795.
6. Takeda K, Goto H, Hirooka Y, et al. Contrast-enhanced transabdominal ultrasonography in the diagnosis of pancreatic mass lesions. Acta Radiologica 2003;44:103-106.
7. Wen YL, Kudo M, Minami Y, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR 2003;181:57-63.
8. Kitano M, Kudo M, Maekawa K, et al. Dynamic imaging of pancreatic diseases by contrast-enhanced coded phase-inversion harmonic ultrasonography. Gut 2004;53:854-859.
9. Minami Y, Kudo M, Kawasaki T, et al. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. AJR 2004;182:1224-1226.
10. Ohshima T, Yamaguchi T, Ishihara T, et al. Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor. Pancreas 2004;28:335-343.
11. Wen YL, Kudo M, Zheng RQ, et al. Characterization of hepatic tumors: value of contrast-enhanced coded phase inversion harmonic US. AJR 2004;182:1019-1026.
12. Masaki T, Ohkawa S, Amano A, et al. Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer 2005;103:1026-1035.
13. Fukuta N, Kitano M, Maekawa K, et al. Estimation of the malignant potential of gastrointestinal stromal tumors: the value of contrast-enhanced coded phase-inversion harmonic US. J Gastroenterol 2005;40:247-255.
14. Numata K, Ozawa Y, Kobayashi N, et al. Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings. J Gastroenterol 2005;40:631-640.
15. Sofuni A, Iijima H, Moriyasu F, et al. Differential diagnosis of pancreatic tumors using contrast imaging. J Gastroenterol 2005;40:518-525.
16. Inoue T, Kitano M, Kudo M, et al. Diagnosis of gallbladder diseases by contrast-enhanced phase-inversion harmonic ultrasonography. Ultrasound Med Biol 2007;33:353-361.
17. Zuccaro G, Sterling MJ. Endosonography in pancreatic disease: differential diagnosis. In: van Dam J, Svak MV, editors. Gastrointestinal endoscopy. New York: Saunders; 1999. p. 235-243.
18. DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004;141:753-763.
19. Gorce JM, Arditi M, Schneider M. Influence of bubble size distribution on the echogenicity of ultrasound agents. Invest Radiol 2000;35:661-671.
20. Baert AL, Sartor K. Contrast media in ultrasonography. Basic principles and clinical applications. Berlin: Springer; 2005.
21. Rickes S, Mönkemüller K, Malfertheiner P. Echo-enhanced ultrasonography with pulse inversion imaging: a new imaging modality for the differentiation of cystic pancreatic tumours. World J Gastroenterol 2006;14:2205-2208.
22. Rickes S, Uhle C, Kahl S, et al. Echo enhanced ultrasound; a new valid initial imaging approach for severe acute pancreatitis. Gut 2006;53:74-78.
23. Kimbel KH. Regulation of ethics committees in Germany. Lancet 1994;344:398.
24. Ueno N, Tomiyama T, Tano S. Contrast-enhanced color Doppler ultrasonography in diagnosis of pancreatic tumor: two case reports. J Ultrasound Med 1996;15:527-530.
25. Bhutani MS, Hoffman BJ, Velse A, Hawes RH. Contrast-enhanced endoscopic ultrasonography with galactose microparticles: SHU508A (Levovist). Endoscopy 1997;29:635-639.
26. Hirooka Y, Naitoh Y, Goto H, et al. Usefulness of contrast-enhanced endoscopic ultrasonography with intravenous injection of sonicated serum albumin. Gastrointest Endosc 1997;46:166-169.
27. Hirooka Y, Goto H, Itoh A, et al. Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study. Am J Gastroenterol 1998;93:632-635.
28. Becker D, Strobel D, Bernatik T, Hahn EG. Echo-enhanced color-and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001;53:784-789.
29. Hocke M, Schulze E, Gottschalk P, et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006;12:46-50.
30. Kanamori A, Hirooka Y, Itoh A, et al. Usefulness of contrast-enhanced endoscopic ultrasonography in the differentiation between malignant and benign lymphadenopathy. Am J Gastroenterol 2006;10:45-51.
31. Sǎftoiu A, Popescu C, Cazacu S, et al. Power Doppler endoscopic ultrasonography for the differential diagnosis between pancreatic cancer and pseudotumoral chronic pancreatitis. J Ultrasound Med 2006;25:363-372.